Once approved, Spravato treatment is covered by Medicaid. For commercial insurance plans, there may be a copay; however, we enroll all eligible patients in the Spravato savings program, which typically reduces the medication cost to no more than $10 per treatment. For Medicaid, the copay for the medication itself is usually around $3. Additionally, Spravato offers rebates that may provide up to $800 per year back toward copay costs. For Medicare plans, costs can vary depending on your specific coverage, and our team will guide you through the approval process and explain any expected out-of-pocket expenses.